Blotzheim, France

Virginie Brom

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Hoffmann-La Roche Inc.. Active years: 2026.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Virginie Brom - Innovator in Pharmaceutical Chemistry

Introduction

Virginie Brom is a notable inventor based in Blotzheim, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on substituted amino-pyrimidines. Her research focuses on developing novel compounds that have potential applications in various therapeutic areas.

Latest Patents

Virginie holds a patent for her invention titled "Substituted amino-pyrimidines." This invention provides novel compounds characterized by a general formula, where specific groups are defined. The patent outlines compositions that include these compounds and methods for utilizing them effectively in medical applications. She has 1 patent to her name, showcasing her commitment to advancing scientific knowledge.

Career Highlights

Virginie is currently employed at Hoffmann-La Roche Inc., a leading global healthcare company. Her role involves extensive research and development, contributing to the creation of innovative pharmaceutical solutions. Her work is instrumental in addressing unmet medical needs and improving patient outcomes.

Collaborations

Throughout her career, Virginie has collaborated with talented professionals, including Luke Green and Christian Kramer. These partnerships have fostered a dynamic research environment, enabling the exchange of ideas and expertise.

Conclusion

Virginie Brom exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions through her patent and collaborative efforts highlight her dedication to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…